2022
DOI: 10.1590/fst.70520
|View full text |Cite
|
Sign up to set email alerts
|

Clinical research for dose effects of ketorolac tromethamine on PCIA after hip arthroplasty

Abstract: Materials and methods Patients' information and operation processThe inclusion criteria were: age ≥ 18 years, intact cognitive function, ASA score ≤ 2, and scheduled for primary unilateral Total hip arthroplasty. Patients who were scheduled for simultaneous or staged bilateral total hip arthroplasty or for revision total hip arthroplasty were excluded. Patients with contraindications for any of the study drugs, due to allergy, regular opioid use,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 17 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?